FDA approves multiple generics of ADHD and BED treatment
www.fda.gov
FDA approves multiple generics of ADHD and BED treatment
  • cravl@slrpnk.netEnglish
    2·
    1 year ago

    Heads up from their website:

    Please note that VYVANSE and MYDAYIS will no longer be available through Help at Hand after December 31, 2023. The completed application with all required supporting documentation must be received and approved by October 16, 2023 in order to continue to receive product from the Help at Hand Patient Assistance Program for the remainder of 2023. Please work with your health care provider to determine the appropriate next steps to best address your individual needs. Enrollees with questions should call 1-800-830-9159.